Posted August 5, 2016

Seller of Fertilix Warned By FDA

On July 22, 2016, the FDA issued a warning letter to CellOxess LLC, following a review of the company's websites, social media pages and marketing literature which found statements made about Fertilix Preconceptual, Fertilix Low Dose and Fertilix Max to be drug claims.

Fertilix supplements are described on the company's website as "synergistic combinations of antioxidants" and "natural product formulations to treat male and female infertility resulting from oxidative stress impacting the reproductive system."

They were promoted with statements such as "A 3 month course of therapy with Fertilix will emich [sic] the number of quality sperm cells in the semen, increasing the chances of a healthy pregnancy and offspring" and " Fertilix ...protects against oxidative damage to sperm DNA and/or membranes in human clinical trials."

See the Encyclopedia article about Female Infertility and Male Infertility for more information about these conditions.

See Related Warnings:

Seller of Vision Supplements Warned for Drug Claims

Maker of Vitamin K, Vitamin A & More Warned for Manufacturing Violations, Drug Claims

Seller of "Hangover" Supplement Warned for Manufacturing Violations & Drug Claims

Seller of "Natural" Cough Syrup Warned for Manufacturing Violations, Drug Claims

Seller of Aloe, Sexual Enhancement Supplements and More Warned for Manufacturing Violations, Drug Claims

Maker of Aloe, Weight Loss Supplements and More Warned for Manufacturing Violations, Drug Claims

To read the FDA's warning letter, use the link below.